IBA (Ion Beam Applications S.A.), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, announces it has signed a contract with the Catholic University of Korea, Seoul St. Mary’s Hospital, one of the largest hospital in South Korea, for a Proteus PLUS1 solution to be installed in Seoul.

The contract includes the equipment of a Proteus PLUS solution with three gantry-room as well as a multi-year service contract. The system will also include DynamicARC 2 beam delivery capabilities, once this feature has received regulatory clearance.

The Seoul St. Mary's Hospital plans to begin patient treatments by the end of 2029. Upon full completion, the center will have eight floors, including underground levels, and a total area of 37,851 square meters.

Olivier Legrain, Chief Executive Officer of IBA, commented: “We are pleased to partner with Seoul St. Mary’s Hospital to bring the latest proton therapy technology in South Korea, expanding the number of centers in the country that benefit from IBA’s proton therapy solutions. This contract highlights the relevance of our offering in markets where demand for this cutting-edge treatment modality is strongly increasing. We look forward to working with the expert medical team of Seoul St. Mary’s to make this technology more accessible to patients.”

LEE Ji Youl, MD, PhD, President of Seoul St. Mary's Hospital, added: “We are pleased to have signed this contract with IBA, the world leader in proton therapy technology, for the introduction of cutting-edge latest-generation equipment. The construction of the center is the final step in completing the Seoul St. Mary's Hospital complex. Our hospital will provide world-best treatment not only in the field of blood cancers, for which it has earned a global reputation, but also in the treatment of solid tumors.”